We are excited to announce that the FDA approved our Investigational Device Exemption application to make use of the CorTec Brain Interchange in a study seeking to enhance stroke rehabilitation through the use of neuroplasticity-inducing stimulation! Pending IRB approval, we will be seeking individuals with persistent upper limb disability following stroke to participate in this first-of-it’s-kind study with this new device. More information will be coming soon, and for more information check out CorTec’s press release here.